GNH USA

Europe — EMA

Montek (Sodium Molybdate (99mo))

GNH USA supplies Montek (Sodium Molybdate), a trace element supplement for molybdenum deficiency and parenteral nutrition. Request a quote for global supply.

Sodium Molybdate (99mo)

Request sourcing

1
Pack/s

What is Sodium Molybdate (99mo)?

Sodium molybdate, the active ingredient in Montek, is a trace element supplement presented as a sterile solution for intravenous and ocular use. It is employed where molybdenum supplementation is required, such as in cases of deficiency or as part of parenteral nutrition regimens.

GNH USA supplies Montek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Sodium Molybdate (99mo) used for?

Montek (sodium molybdate) is used primarily to address molybdenum deficiency and to provide essential trace element support in clinical nutrition. - Molybdenum deficiency: restores normal activity of molybdenum‑dependent enzymes. - Parenteral nutrition: supplies an essential trace element in total nutrient admixtures. - Ophthalmic procedures: used as an adjunct in certain ocular surgeries requiring molybdenum supplementation.

What are the side effects of Sodium Molybdate (99mo)?

Sodium molybdate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Nausea: transient feeling of queasiness. - Headache: mild to moderate headache. - Flushing: temporary reddening of skin. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hypotension: sudden drop in blood pressure. - Renal impairment: worsening kidney function in susceptible patients. - Hepatotoxicity: liver enzyme elevations indicating possible liver stress.

What precautions apply to Sodium Molybdate (99mo)?

When using sodium molybdate, clinicians should observe several precautionary measures to ensure patient safety. - Renal function: assess kidney function before and during therapy. - Allergy history: verify no known hypersensitivity to molybdenum compounds. - Pregnancy and lactation: use only if potential benefit outweighs unknown risks. - Concomitant trace elements: monitor for imbalance when combined with other mineral supplements. - Drug interactions: review patient medications for agents that may alter molybdenum metabolism. - Store at below 25°C: keep in original container, protect from moisture and light.

What does Sodium Molybdate (99mo) interact with?

Sodium molybdate can interact with certain medicines and supplements, affecting its efficacy or safety.

Major Interactions (Avoid): - Chelating agents: may bind molybdenum and reduce its availability. - High-dose copper supplements: can interfere with molybdenum absorption.

Moderate Interactions (Monitor Closely): - Anticoagulants: molybdenum may potentiate bleeding risk. - Diuretics: may alter electrolyte balance influencing molybdenum handling. - Vitamin B12 therapy: concurrent use may require monitoring of metabolic parameters.

Frequently asked questions

What is Montek used for?+
Montek contains sodium molybdate, which is used to provide molybdenum, an essential trace element, in patients with documented molybdenum deficiency, as part of parenteral nutrition formulations, or in specific ophthalmic procedures where molybdenum supplementation is indicated.
How does sodium molybdate work in the body?+
Sodium molybdate releases molybdenum ions that become part of the molybdenum cofactor, a critical component for enzymes such as sulfite oxidase, xanthine oxidase and aldehyde oxidase. These enzymes facilitate sulfur amino‑acid metabolism, purine breakdown and detoxification processes.
What is the usual dose of Montek?+
The dosage of Montek is determined by the prescribing clinician based on the patient’s clinical condition, route of administration, and laboratory assessments. No fixed regimen is provided here; the prescriber sets the appropriate dose.
Is Montek safe during pregnancy or breastfeeding?+
Safety data for sodium molybdate in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician.
How do I order Montek from GNH USA?+
To request Montek, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Montek compare with other molybdenum supplements?+
Montek provides sodium molybdate in a sterile injectable form, which offers precise dosing and rapid bioavailability compared with oral molybdenum compounds. This makes it suitable for patients requiring immediate trace‑element repletion, such as those on total parenteral nutrition, whereas oral supplements are generally used for mild deficiencies.
What are the storage and handling requirements for Montek?+
Montek should be stored at temperatures below 25 °C, protected from moisture and direct light. Keep the vial in its original packaging until use, and discard any product that appears discolored or contains particles.
How is Montek administered?+
Montek is administered either by intravenous infusion or as an ocular injection, depending on the clinical indication. The exact administration technique, rate, and dilution (if any) are determined by the healthcare professional overseeing the treatment.
What are the most serious risks associated with Montek?+
Serious risks include anaphylactic reactions, sudden hypotension, renal impairment, and hepatotoxicity. Patients should be monitored closely for signs of allergic response, blood pressure changes, and liver or kidney function abnormalities during and after administration.
Who should not receive Montek?+
Montek is contraindicated in individuals with known hypersensitivity to sodium molybdate or any component of the formulation. Caution is also advised for patients with severe renal or hepatic dysfunction, and it should be avoided in pregnant or breastfeeding women unless clearly justified by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sodium Molybdate (99mo)
Route
Intravenous Use , Ocular Use
Manufacturer
Monrol Europe Srl
Origin
EU

Related products

Monroltec

Monroltec

Sodium Molybdate (99mo)

Monrol Europe Srl
EU
Montek

Montek

Sodium Molybdate (99mo)

Monrol Europe Srl
EU
Montek

Montek

Sodium Molybdate (99mo)

Monrol Europe Srl
EU
Montek

Montek

Sodium Molybdate (99mo)

Monrol Europe Srl
EU